Chen Schor
CIK 1340875 · President & CEO · last filed 2026-06-23
Chen Schor is a President & CEO who has filed 66 SEC Form 4 insider transactions across 6 companies since 2007. The most recent filing, for ACET, was dated Jun 23, 2026. Across all open-market trades the lifetime net is −$5.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $188.1K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$188.1K
6
66
-$5.08M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ACET | President & CEO | 9,536 | $8.20 | $78.2K | -$5.13M | 35 | 2026-06-23 |
| KPTI | Director | 15,508 | $7.09 | $110.0K | $0 | 7 | 2026-05-26 |
| Adicet Bio, Inc. (TORC) Delisted | President and CEO | 319,480 | — | — | $53.5K | 6 | 2019-12-06 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) Delisted | Director | 8,371 | $0.75 | $6.3K | $0 | 4 | 2018-12-21 |
| MADRIGAL PHARMACEUTICALS, INC. (SNTA) Delisted | Former President and CEO | 37,178 | — | — | $0 | 5 | 2016-07-22 |
| EPIX Pharmaceuticals, Inc. (EPIX) Delisted | Chief Business Officer | 7,312 | $0.20 | $1.5K | $0 | 6 | 2009-03-03 |
Recent Filings
66 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-23 | ACET | Grant (A) | — | $0 | EDGAR |
| 2026-05-26 | KPTI | Grant (A) | +15,508 | $0 | EDGAR |
| 2026-03-27 | ACET | Grant (A) | — | $0 | EDGAR |
| 2026-01-27 | ACET | Tax (F) | −1,755 | -$14.8K | EDGAR |
| 2025-05-29 | KPTI | Grant (A) | — | $0 | EDGAR |
| 2025-02-04 | ACET | Grant (A) | — | $0 | EDGAR |
| 2025-01-28 | ACET | Tax (F) | −28,101 | -$25.9K | EDGAR |
| 2024-06-07 | ACET | Grant (A) | — | $0 | EDGAR |
| 2024-05-30 | KPTI | Grant (A) | — | $0 | EDGAR |
| 2024-01-26 | ACET | Mixed | +55,010 | -$36.7K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.